The role of TSH receptor antibodies in the management of Graves' disease

European Journal of Internal Medicine

Volumn 22, Issue 3, 2011, Pages 213-216

  Matthews, David C ^a   Syed, Akheel A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Graves' disease; TBII; Thyroid disease; TSAb; TSH receptor antibodies

Indexed keywords

LIOTHYRONINE; MICROSOME ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ANTIBODY TITER; ANXIETY; BLOOD EXAMINATION; CASE REPORT; CLINICAL DECISION MAKING; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; EXOPHTHALMOS; FEMALE; GOITER; GRAVES DISEASE; HEART BEAT; HUMAN; HYPERTHYROIDISM; INSOMNIA; MALE; OPHTHALMOPLEGIA; PATHOGENESIS; PATIENT CARE; PERIORBITAL EDEMA; PREGNANCY; PULSE RATE; REVIEW; THIRD TRIMESTER PREGNANCY; THYROID DISEASE; THYROIDITIS; THYROTOXICOSIS; TREMOR; WEIGHT REDUCTION;

EID: 79956031402     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.02.006     Document Type: Short Survey

References (30)

1. Davies TF, Roti E, Braverman LE, DeGroot LJ. Thyroid controversy - stimulating antibodies. J Clin Endocrinol Metab 1998;83:3777-85. (Pubitemid 28513550)
2. Davies TF, Yeo PP, Evered DC, Clark F, Smith BR, Hall R. Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. Lancet 1977;1:1181-2.
3. Roti E, Braverman LE, DeGroot LJ. TSH receptor antibody measurement in the diagnosis and management of Graves' disease is rarely necessary. J Clin Endocrinol Metab 1998;83:3781-4.
4. Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf) 2001;55:381-90. (Pubitemid 32823048)
5. Abraham P, Avenell A, McGeoch SC, Clark LF, Bevan JS. Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database Syst Rev 2010:CD003420.
6. McKenna TJ. Graves' disease. Lancet 2001;357:1793-6. (Pubitemid 32524228)
7. Weetman AP. Graves' disease. N Engl J Med 2000;343:1236-48.
8. Davies TF. Thyroid-stimulating antibodies predict hyperthyroidism. J Clin Endocrinol Metab 1998;83:3777-81.
9. Downs H, Meyer AA, Flake D, Solbrig R. Clinical inquiries: how useful are autoantibodies in diagnosing thyroid disorders? J Fam Pract 2008;57:615-6.
10. Cappelli C, Pirola I, De Martino E, Agosti B, Delbarba A, Castellano M, et al. The role of imaging in Graves' disease: a cost-effectiveness analysis. Eur J Radiol 2008;65:99-103.
11. Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF. A monoclonal thyroid-stimulating antibody. J Clin Invest 2002;110:1667-74. (Pubitemid 35424245)
12. Thyroid autoantibodies (TPOAb, TGAb and TRAb). Thyroid 2003;13:45-56.
13. Ajjan RA, Weetman AP. Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab 2008;4:461-8.
14. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999;84:90-7. (Pubitemid 29036685)
15. Paunkovic J, Paunkovic N. Does autoantibody-negative Graves' disease exist? A second evaluation of the clinical diagnosis. Horm Metab Res 2006;38:53-6.
16. Villalta D, Orunesu E, Tozzoli R, Montagna P, Pesce G, Bizzaro N, et al. Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers. J Clin Pathol 2004;57:378-82.
17. Smith BR, Bolton J, Young S, Collyer A, Weeden A, Bradbury J, et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 2004;14:830-5. (Pubitemid 39489008)
18. Schott M, Hermsen D, Broecker-Preuss M, Casati M, Mas JC, Eckstein A, et al. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial. Clin Endocrinol (Oxf) 2009;71:566-73.
19. Vos XG, Smit N, Endert E, Tijssen JG, Wiersinga WM. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study. Clin Endocrinol (Oxf) 2008;69:311-7. (Pubitemid 352009024)
20. Wilson R, McKillop JH, Henderson N, Pearson DW, Thomson JA. The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease. Clin Endocrinol (Oxf) 1986;25:151-6. (Pubitemid 16046352)
21. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev 2001;22:240-54. (Pubitemid 32458161)
22. Franklyn JA. What is the role of radioiodine uptake measurement and thyroid scintigraphy in the diagnosis and management of hyperthyroidism? Clin Endocrinol (Oxf) 2010;72:11-2.
23. Okosieme OE, Chan D, Price SA, Lazarus JH, Premawardhana LD. The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism. Clin Endocrinol (Oxf) 2010;72:122-7.
24. Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009;160:1-8.
25. Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998;139:584-6. (Pubitemid 29030394)
26. Harvey RD, Metcalfe RA, Morteo C, Furmaniak W, Weetman AP, Bevan JS. Acute pre-tibial myxoedema following radioiodine therapy for thyrotoxic Graves' disease. Clin Endocrinol (Oxf) 1995;42:657-60 discussion 661.
27. DeGroot LJ. Radioiodine and the immune system. Thyroid 1997;7:259-64.
28. Syed AA, Jones NA, Perros P. Acute pretibial myxoedema following thyroidectomy for Graves' disease. NZ Med J 2008;121:108-9.
29. Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, et al. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 1998;83:40-6. (Pubitemid 28498308)
30. Syed AA, Evans C, Ludgate M, Lazarus JH. Early changes in thyroid-stimulating antibody activity following radioiodine therapy. Med Princ Pract 2003;12:266-8. (Pubitemid 37505756)